Enanta Pharmaceuticals, Inc. (ENTA)
$11.52-6.34%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $335M
- Beta
- 0.96
- P/E (TTM)
- -4.78
- Short % float
- 10.09%
- Days to cover
- 9.2
- SI change
- -1.8%
- 1W
- -5.34%
- 1M
- -12.20%
- vs SPY 1W
- -5.20%
- vs SPY 1M
- -14.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ENTA?
- LOPJLB’s latest quantitative signal on Enanta Pharmaceuticals, Inc. (ENTA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ENTA in?
- Enanta Pharmaceuticals, Inc. (ENTA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Enanta Pharmaceuticals, Inc. (ENTA) do?
- Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV). Th…